GTHRX Mutual Fund

NAV$40.36

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.32%
Dividend Yield (Current)
5.49%
Holdings
81
Inception Date
Sep 30, 2025
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.40%

Asset Allocation

Stocks: 95.79%
Cash: 4.21%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company9.07%
JNJJOHNSON AND JOHNSON5.81%
AZN:LNAstrazeneca Plc Adr4.34%
GILDGilead Sciences Inc4.10%
ABBVAbbvie Inc Health Care3.67%
Top 10 Concentration: 42.62%Report Date: Mar 31, 2026
Download all 81 holdings for GTHRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
5.49%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how GTHRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

GTHRX Mutual Fund Overview

GTHRX Mutual Fund (Invesco Health Care Fund Class R) is managed by Invesco (US). GTHRX expense ratio is 1.32%, holding 81 positions across sectors including Health Care, Unknown, Real Estate. Inception date: 2025-09-30.

GTHRX performance shows a YTD return of 3.40%.. GTHRX dividend yield stands at 5.49%, paid annually.

GTHRX top holdings include Eli Lilly And Company (9.1%), JOHNSON AND JOHNSON (5.8%), Astrazeneca Plc Adr (4.3%), Gilead Sciences Inc (4.1%), Abbvie Inc Health Care (3.7%). View all GTHRX holdings, sector breakdown, or dividend history.

GTHRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GTHRX alternatives are available via the screener, along with tax-loss harvesting opportunities.